Cleaning Validation Limits for a Shared Fluid-Bed Dryer
A shared fluid-bed dryer processes Product A, whose API has a permitted daily exposure (PDE) of 2 µg/day. The A batch size is 250 kg, and the product-contact surface area is 20 m². The next product, B, has a maximum daily dose of 1600 mg (four 400 mg tablets). Cleaning uses 200 L of purified water as the final rinse. Swabs cover 25 cm², the analytical recovery is 75%, and the rinse/swab LOQ is 0.2 µg/mL or 0.2 µg/swab. The site currently releases the dryer on rinse results alone; visual inspection is done under normal light. A rinse sample from the last run reads 1.1 µg/mL, and an uncorrected swab from the exhaust duct reads 45 µg/swab. The QA group wants to know whether the equipment is clean and whether the sampling plan is defensible.
1. Calculate the maximum allowable carryover, the swab limit, and the rinse limit, stating your assumptions.
Read the worked answer
Use the PDE-based carryover equation: MACO = PDE × minimum batch size of the next product / maximum daily dose of the next product. Here MACO = 2 µg/day × 250,000,000 mg / 1600 mg = 312,500 µg = 312.5 mg. This assumes the entire 250 kg batch could be contaminated and that Product B is the next worst case. Swab limit before recovery = MACO × swab area / total product-contact area = 312.5 mg × 25 cm² / 200,000 cm² = 0.0391 mg = 39.1 µg/swab. Correcting for 75% recovery gives 39.1 / 0.75 = 52.1 µg/swab. Rinse limit = MACO / rinse volume = 312.5 mg / 200 L = 1.56 mg/L = 1.56 µg/mL. These limits are well above the LOQ, so the analytical method is capable. The calculation must be documented with the surface-area map and the basis for the 200 L rinse volume.
2. Interpret the rinse and swab results. Is the dryer clean, and what action follows?
Read the worked answer
The rinse result of 1.1 µg/mL is below the 1.56 µg/mL rinse limit, so the rinse result passes. The swab result is reported as uncorrected: 45 µg/swab. Corrected for 75% recovery, the residue is 45 / 0.75 = 60 µg/swab, which exceeds the 52.1 µg/swab limit. Therefore the equipment does not meet the acceptance criterion at that location. If the laboratory had already reported a recovery-corrected result, 45 µg/swab would pass, so the first action is to confirm the reporting convention. Assuming the setup is correct, the exhaust duct is a credible worst-case location and the failure triggers an investigation: re-clean, resample with replicates, inspect the duct for buildup, check spray coverage, and evaluate whether the rinse sampled the same surface. The batch should not be released on rinse alone.
3. Critique the rinse-only release strategy and propose a defensible sampling plan.
Read the worked answer
Rinse-only release is weak for a potent API because residues can adsorb to surfaces, hide in crevices, or be unevenly wetted. The rinse result measures the water phase, not necessarily the surface. Visual inspection under normal light is also insufficient for a 2 µg/day PDE compound. A defensible plan combines visual inspection under controlled lighting, direct swab sampling at worst-case locations, and rinse sampling for large or inaccessible surfaces. Include the exhaust duct, corners, seams, and product-contact zones; sample at least five to ten sites based on a surface map, with replicate swabs at the worst case. Establish recovery per material, hold-time limits, and acceptance criteria before execution. Reserve the right to use the worst-case product based on PDE, solubility, batch size, and contact area. Document deviations and investigate any failed site before release.